Alzamend Neuro (ALZN) Change in Accrued Expenses (2022 - 2026)
Alzamend Neuro (ALZN) recorded Change in Accured Expenses of $1.39 million in fiscal Q1 2027 (quarter ended Jul 31, 2026), up 299.7% from $348,550 a year earlier.
Powered by 
Analysis
Alzamend Neuro (ALZN) Change in Accrued Expenses (2022 - 2026) Analysis & Trends
On a TTM basis, Alzamend Neuro's Change in Accured Expenses came in at $1.76 million as of Jul 31, 2026; for FY2026 (ended Apr 30, 2026), it came in at $711,391.
- Annual Change in Accured Expenses has a three-year compound annual growth rate of -25.3% (FY2023 to FY2026).
- Across earlier fiscal years, Change in Accured Expenses came in at -$2.29 million in FY2025, $54,937 in FY2024 (-96.8%) and $1.71 million in FY2023.
- The fiscal Q1 2027 figure is the highest quarterly Change in Accured Expenses since fiscal Q3 2023.
- Per Business Quant, the preceding three fiscal quarters came in at -$511,176 (Q4 2026), $1.14 million (Q3 2026) and -$265,823 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Alzamend Neuro | 6.51 Mn | -8.95 Mn | - | 1.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 1.39 Mn |
| Apr 30, 2026 | -511,176.00 |
| Jan 31, 2026 | 1.14 Mn |
| Oct 31, 2025 | -265,823.00 |
| Jul 31, 2025 | 348,550.00 |
| Apr 30, 2025 | -3,711.00 |
| Jan 31, 2025 | -616,278.00 |
| Oct 31, 2024 | -1.63 Mn |
| Jul 31, 2024 | -41,532.00 |
| Apr 30, 2024 | -901,398.00 |
| Jan 31, 2024 | 160,367.00 |
| Oct 31, 2023 | 925,202.00 |
| Jul 31, 2023 | -129,234.00 |
| Apr 30, 2023 | 227,649.00 |
| Jan 31, 2023 | 1.99 Mn |
| Oct 31, 2022 | -378,499.00 |
| Jul 31, 2022 | -136,232.00 |
API Access
Alzamend Neuro Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();